Mainstreet Drugs, Inc
Community/Retail Pharmacy
2319 Cogswell Ave, Ste 400, Pell City
Alabama, 35125-1734
205-369-2391 205-629-7450
Mainstreet Drugs, Inc is an authorized DME supplier for medicare equipments and products.
Mainstreet Drugs, Inc is a Community/Retail Pharmacy in Pell City, Alabama. It is located at 2319 Cogswell Ave, Ste 400, Pell City and it's customer support contact number is 205-369-2391. The authorized person of Mainstreet Drugs, Inc is Mr. Curtis Marshall Eddy, PHARM D who is Owner/pharmacist of the pharmacy and his contact number is 205-629-6303. Active license number of Mainstreet Drugs, Inc is 114328 for Community/Retail Pharmacy in Alabama. Mainstreet Drugs, Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Mainstreet Drugs, Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Mainstreet Drugs, Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Mainstreet Drugs, Inc |
| Type: | Community/Retail Pharmacy |
| Location: | 2319 Cogswell Ave, Ste 400, Pell City, Alabama, 35125-1734 |
| Phone: | 205-369-2391 |
| Fax: | 205-629-7450 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Mr. Curtis Marshall Eddy |
| Credentials: | PHARM D |
| Position: | Owner/pharmacist |
| Contact Number: | 205-629-6303 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1043638356 |
| NPI Enumeration Date: | 03 Apr, 2014 |
| NPI Last Update On: | 01 May, 2014 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mainstreet Drugs, Inc are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 114328 | Alabama | Primary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 158709 | Medicaid | Alabama | |
Medicare Enrollment:
Mainstreet Drugs, Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 2961712872 | O20151105000689 | Mainstreet Drugs, Inc | PART B SUPPLIER - OTHER |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | Po Box 787, Odenville, Alabama |
| Zip: | 35120-0787 |
| Phone Number: | 205-369-2391 |
| Fax Number: | 205-629-7450 |
Patients can reach Mainstreet Drugs, Inc at
2319 Cogswell Ave, Ste 400, Pell City, Alabama or can
call on customer care at 205-369-2391.
Comments/ Reviews:
Read all the reviews posted for Mainstreet Drugs, Inc below. You may also share your own experience with Mainstreet Drugs, Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.